YAP/TAZ enhances P-body formation to promote tumorigenesis
eLife · 2024
DOI: 10.7554/elife.88573 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Xia Shen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal and Anal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: YAP-Signaling Proteins, Adaptor Proteins, Signal Transducing, Transcription Factors, Carcinogenesis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning.
Abstract (Originalsprache)
The role of processing bodies (P-bodies) in tumorigenesis and tumor progression is not well understood. Here, we showed that the oncogenes YAP/TAZ promote P-body formation in a series of cancer cell lines. Mechanistically, both transcriptional activation of the P-body-related genes SAMD4A, AJUBA , and WTIP and transcriptional suppression of the tumor suppressor gene PNRC1 are involved in enhancing the effects of YAP/TAZ on P-body formation in colorectal cancer (CRC) cells. By reexpression of PNRC1 or knockdown of P-body core genes ( DDX6, DCP1A, and LSM14A ), we determined that disruption of P-bodies attenuates cell proliferation, cell migration, and tumor growth induced by overexpression of YAP 5SA in CRC. Analysis of a pancancer CRISPR screen database (DepMap) revealed co-dependencies between YAP/TEAD and the P-body core genes and correlations between the mRNA levels of SAMD4A, AJUBA, WTIP, PNRC1, and YAP target genes. Our study suggests that the P-body is a new downstream effector of YAP/TAZ, which implies that reexpression of PNRC1 or disruption of P-bodies is a potential therapeutic strategy for tumors with active YAP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Colorectal and Anal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Colorectal Cancer Research Center, Shanghai, China.
- State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Wei Yu, Yun Liu, Chen-Ying Liu
Förderung
- National Natural Science Foundation of China
- Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
Zitieren
APA
Shen, X., Peng, X., Guo, Y., Dai, Z., Cui, L., Yu, W., Liu, Y., & Liu, C. Y. (2024). YAP/TAZ enhances P-body formation to promote tumorigenesis. eLife. https://doi.org/10.7554/elife.88573
Vancouver
Shen X, Peng X, Guo Y, Dai Z, Cui L, Yu W, et al. YAP/TAZ enhances P-body formation to promote tumorigenesis. eLife. 2024. doi:10.7554/elife.88573
BibTeX
@article{Shen2024,
author = {Shen, Xia and Peng, Xiang and Guo, YueGui and Dai, Zhujiang and Cui, Long and Yu, Wei and Liu, Yun and Liu, Chen-Ying},
title = {YAP/TAZ enhances P-body formation to promote tumorigenesis},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.88573}
}
EUVIMED